Matthew M. Kavanagh & Moderna

Matthew M. Kavanagh: Matthew M. Kavanagh>>>, director of the Georgetown University Center for Global Health Policy and Politics>>>, highlighted the challenges of 'playing catch-up' against the dangerous pathogen due to initial false negative tests.

Moderna: Moderna is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.

Matthew M. Kavanagh: Matthew M. Kavanagh>>>, director of the Georgetown University Center for Global Health Policy & Politics, criticized the delayed detection of the Uganda — Bundibugyo strain and the impact of US aid cuts on surveillance systems.

Moderna: Moderna is one of the entities developing an experimental vaccine for the Bundibugyo virus, which could lead to future revenue and enhance its reputation in vaccine development.